Sputnik V launched: Russia dispatches first batches of pioneering Covid-19 vaccine to all of its 85 regions
Russia has sent out the initial batches of the world’s first registered coronavirus vaccine to all parts of its vast territory, as authorities test the delivery system of the much-needed drug.
The formula is expected to be delivered on Monday, said Russia’s Health Minister Mikhail Murashko. “The first small batches have already been shipped,” Murashko said, explaining that the government is testing the supply chain to ensure a robust delivery system across the country’s 85 regions. As well as testing the efficacy and safety of the vaccine itself, the government believes it is paramount to ensure the efficient distribution to citizens, especially to those at high risk.
Russia’s homegrown Covid-19 formula is currently in the third and final stage of clinical trials, in which 40,000 Muscovites will take part. While three-quarters will receive the jab, another quarter will be given a placebo. On Wednesday, Moscow’s Deputy Mayor Anastasia Rakova announced that testing had begun, and over 35,000 residents had applied.Also on rt.com Almost half of Russians say they don’t want to be vaccinated against Covid-19 & 43% believe dangers of coronavirus are exaggerated
“Clinical trials have begun in Moscow,” Murashko said, adding that the ministry had also created “the world’s first mobile application” that allows participants to “report on their condition” throughout the lengthy trial period.
On August 11, Russian President Vladimir Putin announced that the country had registered the world’s first Covid-19 vaccine, named Sputnik V. It is being produced by Moscow’s Gamaleya Research Institute of Epidemiology and Microbiology. The vaccine’s development process has been criticized by some Western countries for its supposedly unsafe rapid development and improper testing. However, earlier this month, the respected British medical journal The Lancet published the Russian Ministry of Health’s Sputnik V study, showing the vaccine to be 100 percent effective, producing antibodies in all 76 participants of early-stage trials.Also on rt.com Sputnik V questions ANSWERED: Head of team financing world’s first Covid-19 vaccine explains formula to critics
Like this story? Share it with a friend!